Trastuzumab Terminated Phase 1 / 2 Trials for HER2 + Breast Cancer / Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs